Artwork

Innhold levert av Kayla Barnes-Lentz. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Kayla Barnes-Lentz eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Gene + Cell Therapy with Dr. Adeel Khan

51:12
 
Del
 

Manage episode 424045806 series 3580260
Innhold levert av Kayla Barnes-Lentz. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Kayla Barnes-Lentz eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Today I am having a super exciting conversation with Dr. Adeel Khan on gene and cell therapy including stem cells, follistatin, peptides and more. I am planning to visit Dr. Khan and experience these therapies for myself in the next few months and will be posting my experience and results.

About Dr. Khan

Dr. Adeel Khan, is a leading figure in the field of gene and cell therapies. Dr. Adeel Khan, who holds an M.D. and is a Canadian Board Certified Physician, specializes in regenerative and cellular medicine.

He is also a recognized authority as a key opinion leader for The American College of Regenerative Medicine, the foremost advocate for best practices in North America. Notably, he co-founded Xalt, a fitness-technology company, and played a pivotal role in the development of their proprietary technologies. Additionally, he serves as the Chief Scientific Officer for Science & Humans, a virtual hormonal health company.

Dr. Khan’s expertise extends globally, as he has treated world champion athletes, members of Royal Families, and celebrities in both Dubai and North America.

Follow Dr. Kahn on Instagram

Visit His Website

Learn More + Sign Up for his Longevity event in Austin, TX!

  continue reading

61 episoder

Artwork
iconDel
 
Manage episode 424045806 series 3580260
Innhold levert av Kayla Barnes-Lentz. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Kayla Barnes-Lentz eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Today I am having a super exciting conversation with Dr. Adeel Khan on gene and cell therapy including stem cells, follistatin, peptides and more. I am planning to visit Dr. Khan and experience these therapies for myself in the next few months and will be posting my experience and results.

About Dr. Khan

Dr. Adeel Khan, is a leading figure in the field of gene and cell therapies. Dr. Adeel Khan, who holds an M.D. and is a Canadian Board Certified Physician, specializes in regenerative and cellular medicine.

He is also a recognized authority as a key opinion leader for The American College of Regenerative Medicine, the foremost advocate for best practices in North America. Notably, he co-founded Xalt, a fitness-technology company, and played a pivotal role in the development of their proprietary technologies. Additionally, he serves as the Chief Scientific Officer for Science & Humans, a virtual hormonal health company.

Dr. Khan’s expertise extends globally, as he has treated world champion athletes, members of Royal Families, and celebrities in both Dubai and North America.

Follow Dr. Kahn on Instagram

Visit His Website

Learn More + Sign Up for his Longevity event in Austin, TX!

  continue reading

61 episoder

همه قسمت ها

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett